Perhaps a Pyrrhic victory

OXFORD - Chiroscience Group plc (LSE:CRO) may have earned a Pyrrhic victory last week when Sweden's Medical Products Agency granted regulatory approval for Chirocaine, CRO's levobupivacaine long-acting local anaesthetic.

The registration opens the door to approval throughout Europe. Unfortunately, plans to launch the product look to be held up by the

Read the full 508 word article

How to gain access

Continue reading with a
two-week free trial.